drug pricing

ICER-VA alliance for formulary management sparks debateThe National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.
Payers need access to pre-approval drug informationPre-drug-approval forecasting and budgeting is increasingly important for payers. Is a safe harbor for manufacturers necessary?
Groups praise lawsuit against Walgreens, CVSPharmacy and medical organizations lauded a new class action lawsuit against CVS Health and Walgreens, alleging the two pharmacy chains colluded with pharmacy benefit managers (PBMs) to drive up the cost of generic drugs.
AAM Report on Generics Finds High Brand Abandonment RatePatients are less like to buy a requested brand name prescription than a generic one.
Are Rebates Responsible for Higher Drug Costs?A new study shows how the Medicare donut hole could be costing patients.
Two strategies to help consumers lower drug costsHealthPartners aims to improve price information for consumers. Here’s how.
Campaign gears up to combat high drug pricesWalmart, CVS Health, and a number of other healthcare organizations are supporting a new multi-million dollar consumer campaign to combat high prescription drug prices.
First progressive MS drug carries high price tagWhile FDA just approved the first drug for primary progressive multiple sclerosis (PPMS), the drug’s price tag is controversial.
Health Care a Central Issue in President Trump’s Speech to CongressIn his address to Congress, Trump hinted at what could be in the future for healthcare reform.
Diabetic patients challenge insulin makersIn the latest flap over the high cost of drugs, diabetes patients filed a class-action lawsuit against insulin makers.